[Drugs in syndromes of dysfunction of arteriovenous anastomoses].
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001163:Arteriovenous Anastomosis / Q000503:physiopathology*; D004837:Epinephrine / Q000494:pharmacology; D004877:Ergoloid Mesylates / Q000627:therapeutic use; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D009705:Nucleosides / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy; D012110:Reserpine / Q000627:therapeutic use; D014648:Varicose Veins / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D009705:Nucleosides; D014665:Vasodilator Agents; D004877:Ergoloid Mesylates; D006632:Histamine; D012110:Reserpine; D010208:Papaverine; D011736:Pyridoxine; D000109:Acetylcholine; D004837:Epinephrine
Médications dans les syndromes de dysfonctionnement des anastomoses artério-veineuses.